Sign In
Buy HIMS
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026
Hims & Hers to Announce Third Quarter 2022 Earnings on November 7, 2022
04:05pm, Monday, 17'th Oct 2022
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences t
Hims & Hers: Just What The Doctor Ordered
10:01am, Friday, 16'th Sep 2022
Hims & Hers has now reported back-to-back quarters with over 100K net new subscriptions. The telehealth platform expects to approach a $540 million annual sales run rate in Q4.
Teladoc Health Gains on Amazon Care's Loss. These Stocks Are Also Rising.
07:54am, Thursday, 25'th Aug 2022
Amazon will shut down its healthcare service business. Telehealth stocks are rising Thursday.
Hims & Hers: Here's A Prescription For Portfolio Dysfunction
11:45pm, Friday, 19'th Aug 2022
Direct-to-patient healthcare is the future. H&H's mission is to make healthcare accessible, affordable, and convenient for everyone.
Up 109% In 3 Months, This Monster Growth Stock Isn't Done Climbing Yet
09:21am, Wednesday, 17'th Aug 2022
There's more where that came from.
Hims & Hers CEO: We deliver health care at prices that are ‘cheaper than insurance'
12:51pm, Tuesday, 09'th Aug 2022
#Hims&HersCEO Hims & Hers Founder & CEO Andrew Dudum joins Yahoo Finance Live to discuss health care costs and birth control access in a post-Roe world.
Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum on Q2 2022 Results - Earnings Call Transcript
10:33pm, Monday, 08'th Aug 2022
Hims & Hers Health, Inc. (NYSE:HIMS ) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Jay Spitzer - Senior Vice President, Investor Relations Andrew Dudum - Chief Execu
This Stock Is Up 30% in 1 Month, With More Upside Ahead
10:45am, Tuesday, 02'nd Aug 2022
What stock soars 30% in this market? Hims & Hers.
Hims & Hers Health: Promising Return Profile
05:46am, Sunday, 17'th Jul 2022
Hims is a stock which the market has punished beyond what is rational. The company is progressing nicely towards profitability and the share price should begin to creep up. The company's value proposi
SVB Securities Sees 26% Downside In This Telehealth Platform
06:33pm, Friday, 15'th Jul 2022 Benzinga
SVB Securities analyst Joy Zhang initiated coverage on Hims & Hers Health Inc (NYSE: HIMS) with an Underperform rating and set a price target of $4 (26% downside).
HIMS operates as a DTC diagnosi
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
02:18pm, Friday, 15'th Jul 2022 Benzinga
Upgrades
B of A Securities upgraded the previous rating for TechnipFMC PLC (NYSE:FTI) from Neutral to Buy. For the first quarter, TechnipFMC had an EPS of $0.03, compared to year-ago quarter EPS of $
Nyxoah SA (NYXH) Stock Jumps 13.2%: Will It Continue to Soar?
12:14pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Nyxoah SA (NYXH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
This Former SPAC Looks Recession-Proof
12:45pm, Monday, 20'th Jun 2022 The Motley Fool
Hims & Hers has the growth and the cash to last.
This Former SPAC Looks Recession-Proof
08:45am, Monday, 20'th Jun 2022
Hims & Hers has the growth and the cash to last.
3 Top Penny Stocks To Watch Before Next Week
09:05pm, Friday, 17'th Jun 2022 PennyStocks
Penny stocks to watch right now.
The post 3 Top Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
